Evaluation of Clinical Outcomes and Costs of a Lifestyle Intervention in Obese Infertile Women

Obesity Clinical Trial

— OF  

Official title:

"Evaluation of Clinical Outcomes and Costs of a Transferable Interdisciplinary Lifestyle Intervention Pre- and Per-pregnancy in Obese Infertile Women"

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01483612
• Other study ID #: CIHR/FRN-114125
• Status: Completed
• Phase: N/A
• Start date: January 20, 2012
• Est. completion date: August 2018

Study information

• Verified date: February 2023
• Source: Université de Sherbrooke
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

BACKGROUND: Obesity increases the risk of polycystic ovary syndrome (PCOS), characterized by anovulatory cycles, but it is also associated with reduced fertility even in ovulatory women. Moreover, obesity increases the costs of assisted human reproduction (AHR) treatments and reduces their efficacy. In addition to fertility disorders, obesity increases significantly the risks of many complications of pregnancy, delivery and neonatal health. However, a modest loss of 5-10% of total body weight can restore ovulation and improve pregnancy rates. OBJECTIVES: 1) To design and implement a multidisciplinary program for lifestyle management of obese women, or overweight women with PCOS, who seek fertility treatment in a secondary AHR center. 2) To evaluate lifestyle benefits of this program and assess its impact on fertility, pregnancy and neonatal outcomes, as compared to a randomly assigned control group and to similar women seen in tertiary AHR centers. 3) To assess cost per live birth, and other measures of cost-effectiveness, of this program compared to the control group and tertiary AHR centers. 4) To effectively transfer knowledge obtained through these activities to relevant stakeholders in the health care and public health sectors. METHODS AND APPROACH: In order to design the program for lifestyle management of obesity in infertile women, we will gather a Committee composed of members of our interdisciplinary research team and relevant collaborators. Objectives 2 and 3 - In order to achieve these objectives, 128 obese women (BMI ≥ 30 kg/m²), or overweight women with PCOS (BMI ≥ 27 kg/m²), consulting at the CHUS fertility clinic will be randomized to our lifestyle program, and will suspend fertility treatments for six months, or to standard fertility treatments, which are directly initiated. The results obtained will also be compared to those of women with the same criteria who will consult in 3 tertiary AHR clinics not offering a similar lifestyle management program. IMPACT: This project is very important as it will generate new knowledge about the implementation, impacts and costs of a new lifestyle management program in obese infertile women. Our project will obtain valuable data on implementability of such a program; on benefits with regard to lifestyle, fertility and maternal and foetal complications during pregnancy; as well as on reduction in cost per live birth and other cost-effectiveness ratio.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 130
• Est. completion date: August 2018
• Est. primary completion date: August 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Obese (BMI = 30kg/m2) infertile women
• Overweight (BMI = 27kg/m2) infertile women with polycystic ovary syndrome

Exclusion Criteria:

• Women older than 40 years old
• Women who went through bariatric surgery
• Women under IVF
• Women for whome IVF is the only recommended treatment
• Women who do not speak french

Related Conditions & MeSH terms

• Female Infertility
• Infertility
• Infertility, Female
• Obesity
• Polycystic Ovary Syndrome

Intervention

Behavioral:
• Interdisciplinary lifestyle intervention
Individual meetings with a dietitian and a kinesiologist at 0, 3, 6 weeks and then every 6 weeks for 18 months or until delivery. A reminder phone call/email will also take place once between each meeting. The program also includes 12 group sessions discussing subjects about nutrition, psychology and demonstration of physical activity.

Locations

Country	Name	City	State
Canada	Centre hospitalier universitaire de Sherbrooke	Sherbrooke	Quebec

Sponsors (3)

Lead Sponsor	Collaborator
Université de Sherbrooke	Canadian Institutes of Health Research (CIHR), Ministere de la Sante et des Services Sociaux

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rates of live birth		Participants who will become pregnant: for the duration before they get pregnant and up to the end of pregnancy, an expected average of 18 months. Participants who will not become pregnant: 18 months
Secondary	Fertility outcomes		18 months
Secondary	Pregnancy outcomes		Participants who will become pregnant: up to the end of pregnancy, an expected average of 18 months of follow-up in the study
Secondary	Neonatal outcomes		Participants who will become pregnant: up to the end of pregnancy, an expected average of 18 months of follow-up in the study
Secondary	Clinical outcomes	Evolution of anthropometric measures, change in lifestyle habits, physical fitness level and evolution of readiness for change.	18 months
Secondary	Cost per life birth, and other measures of cost-effectiveness	All costs (interventions and complications) to achieve one life birth, including either all women with a life birth or all enrolled women (by intervention arm).	Participants who will become pregnant: for the duration before they get pregnant and up to the end of pregnancy, an expected average of 18 months. Participants who will not become pregnant: 18 months
Secondary	Clinical outcomes in male partners	Evolution of anthropometric measures and change in lifestyle habits in male partners.	18 months
Secondary	Clinical outcomes of female participants	Evolution of anthropometric measures, changes in lifestyle habits (diet, exercise, alcohol, tobacco), physical fitness level, evolution of readiness for change, etc.	18 months